Global Pharma Execs Hail ‘Unprecedented’ Speed &…
During the fourth International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) COVID-19 media briefing, one thematic dominated:…
Tagged with IFPMA
New Billion Dollar Pharma Action Fund to Counter ‘Slow…
June 9th 2020 saw the launch of a new action fund on antimicrobial resistance (AMR), with 23 leading biopharmaceutical companies committing to almost…
What Can a Plasma ‘Alliance’ do for COVID-19?
A newly formed ‘Plasma Alliance’ of the world’s leading blood plasma companies believed that plasma from those who have recovered from COVID-19…
Speeding up the Search for Safe & Effective COVID-19…
IFPMA Director General Thomas B. Cueni shares the outcomes of a recent high level pharma industry media briefing on the search for a COVID-19…
Lilly CEO David Ricks on Pharma’s Response to COVID-19
During a global virtual press briefing on 19 March 2020, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)…
5 Questions to 5 Leading Pharma Execs on the COVID-19 Pandemic
The CEOs and top executives, David Ricks, chairman and CEO, Eli Lilly & Co and IFPMA president, Severin Schwan, CEO, Roche, Paul Stoffels, chief…
The IFPMA’s New Guidance on Patient & Patient Organisation…
Earlier this month, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) issued new guidance for the pharmaceutical…
Collaboration: The IFPMA’s Route to Reaching the…
With sustainable development goals in mind, the global umbrella pharmaceutical association IFPMA has recently launched a platform that fosters…
PharmaBoardroom’s Women to Watch
Annually, PharmaBoardroom conducts hundreds of interviews with global CEO’s, country managers and industry leaders in the pharma industry. While we…
Smart Economics: The Dividend of Gender Equality
Technology and social media has given women and oppressed minorities a platform in which to vent their frustrations regarding the prevalent…
The IFPMA’s New Code of Practice: PharmaBoardroom Readers…
Across the month of January, we at PharmaBoardroom surveyed our executive readership on attitudes towards the International Federation of…
Melissa Barnes & Thomas Cueni on the IFPMA’s New Code…
Eli Lilly and Company’s Melissa Barnes, who chairs the Ethics and Business Integrity Committee (eBIC) at the International Federation of…
